Clinical Trials
28 trialsSTARTRK-2
Hoffmann-La Roche
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Universitaire Ziekenhuizen KU Leuven
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
STARTRK-NG
Hoffmann-La Roche
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
HiPPI
Emory University
18F-DOPA II - PET Imaging Optimization
University of Alberta
Evaluation of the CONVIVO System
Dartmouth-Hitchcock Medical Center
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
F-Tryptophan PET/CT in Human Cancers
Barbara Ann Karmanos Cancer Institute
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
PRIDE
Tata Memorial Centre
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Jonsson Comprehensive Cancer Center
NARCiS
Universitaire Ziekenhuizen KU Leuven
ALpha-T
Hoffmann-La Roche
Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas
Medical College of Wisconsin
FGR
Dartmouth-Hitchcock Medical Center
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Medical College of Wisconsin
Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes
University of Manitoba
Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors
University of Cincinnati
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
HIPPO-SPARE 01
University of Erlangen-Nürnberg Medical School
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
National Cancer Institute (NCI)
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
Novartis
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)